By Counterforce Health Team in Xenpozyme (olipudase alfa-rpcp) —

Work With Your Doctor to Get Xenpozyme (olipudase alfa-rpcp) Approved by UnitedHealthcare in Georgia: Complete Provider Collaboration Guide

Answer Box: Getting Xenpozyme Covered by UnitedHealthcare in Georgia

To get Xenpozyme (olipudase alfa-rpcp) approved by UnitedHealthcare in Georgia, you'll need: confirmed ASMD diagnosis with genetic testing and enzyme assay, prior authorization through your doctor, and a medical necessity letter documenting failed treatments and functional impact. If denied, Georgia law gives you 60 days to request external review through the Georgia Department of Insurance. Start today by scheduling a visit with your prescribing specialist to gather diagnostic records and treatment history.

Table of Contents

Set Your Goal: Understanding What Approval Requires

Getting Xenpozyme covered by UnitedHealthcare requires a collaborative approach with your healthcare provider. This isn't just about filling out forms—it's about building a compelling clinical case that demonstrates medical necessity for this specialized enzyme replacement therapy.

Your partnership with your doctor should focus on three key areas:

  1. Diagnostic confirmation: Documenting your ASMD diagnosis with both genetic testing (SMPD1 gene variants) and enzyme assay showing <10% normal acid sphingomyelinase activity
  2. Clinical evidence: Proving that Xenpozyme addresses non-CNS manifestations like hepatosplenomegaly, lung disease, or blood abnormalities that impact your daily life
  3. Treatment justification: Showing why supportive care alone isn't sufficient and why this $7,576+ per vial therapy is medically necessary
Note: UnitedHealthcare requires prior authorization for Xenpozyme through their specialty pharmacy OptumRx, and approval rates for specialty drugs have faced increased scrutiny in recent years.

Visit Preparation: Documenting Your Journey

Before meeting with your doctor, create a comprehensive timeline of your ASMD journey. This preparation will help your provider write a stronger medical necessity letter and prepare for potential peer-to-peer reviews.

Symptom Timeline to Document:

  • When you first noticed symptoms (fatigue, enlarged spleen, breathing difficulties)
  • How symptoms have progressed or worsened over time
  • Specific functional limitations (can't climb stairs, frequent hospitalizations, missed work/school days)
  • Any emergency room visits or complications

Treatment History to Compile:

  • All medications tried for ASMD management (even supportive care)
  • Outcomes of each treatment (helped, didn't help, side effects)
  • Why each treatment was discontinued
  • Current medications and their effectiveness

Functional Impact Notes:

  • Daily activities you can no longer perform
  • How ASMD affects your work, school, or family responsibilities
  • Quality of life changes you've experienced
  • Caregiver assistance you now require
Tip: Keep a symptom diary for 2-3 weeks before your visit. Note energy levels, pain, breathing difficulties, and activity limitations. This real-time data strengthens your case.

Building Your Evidence Kit

Work with your healthcare team to gather the documentation UnitedHealthcare requires. Missing pieces can delay approval or lead to denials.

Essential Lab and Imaging:

  • Genetic testing report showing SMPD1 pathogenic variants
  • Enzyme assay results (acid sphingomyelinase activity <10% of normal)
  • Recent CBC with platelets, liver function tests
  • Spleen and liver imaging (ultrasound, CT, or MRI with measurements)
  • Pulmonary function tests if you have lung involvement

Published Guidelines to Reference: Your doctor should cite evidence from:

Medication History Summary: Create a one-page summary listing:

  • All ASMD-related treatments attempted
  • Duration of each treatment
  • Reason for discontinuation
  • Current supportive care medications

Medical Necessity Letter Structure

Your doctor's medical necessity letter is the cornerstone of your approval request. Here's what it should include:

Patient Information & Diagnosis

  • Confirmed ASMD diagnosis with ICD-10 codes (E75.241, E75.244, etc.)
  • Genetic testing and enzyme assay results
  • Date of diagnosis and confirming specialist

Clinical Presentation

  • Non-CNS manifestations present (hepatosplenomegaly, lung disease, cytopenias)
  • Quantified organ involvement (spleen volume, liver size, platelet counts)
  • Functional impact on daily activities and quality of life

Treatment Rationale

  • Why Xenpozyme is medically necessary for your specific case
  • Evidence that supportive care alone is insufficient
  • Expected clinical benefits based on trial data
  • Monitoring plan for treatment response

Supporting Evidence

  • References to FDA labeling and clinical trials
  • Citation of relevant medical literature
  • Specialist credentials and contact information
From our advocates: One patient's approval was initially denied for "insufficient documentation of functional impact." The provider rewrote the letter with specific examples: "Patient can no longer work full-time due to fatigue, requires assistance with grocery shopping, and has been hospitalized twice for respiratory complications." The resubmission was approved within 10 days.

Counterforce Health helps patients and providers create targeted medical necessity letters that address specific payer requirements and denial patterns, turning insurance obstacles into approval opportunities.

Peer-to-Peer Review Support

If your initial prior authorization is denied, UnitedHealthcare offers peer-to-peer reviews where your doctor can speak directly with a medical director. Your role is to support your provider's preparation.

How to Help Your Doctor Prepare:

  • Provide availability windows when you can be reached for additional questions
  • Create a concise case summary (one page) highlighting key points
  • Gather any additional documentation requested after the initial denial
  • Be available to clarify patient-specific details during the review

Key Talking Points for Your Provider:

  • Confirmed genetic diagnosis with specific SMPD1 variants
  • Quantified organ involvement and functional limitations
  • Previous treatment failures and contraindications
  • Evidence from ASCEND trials supporting efficacy
  • Risks of delaying treatment (disease progression, complications)

Timeline for Peer-to-Peer:

  • Request within 24 hours of denial notification
  • Review typically scheduled within 3-5 business days
  • Decision usually provided within 48 hours of the call

After Your Visit: Next Steps

Documents to Save:

  • Copy of the medical necessity letter
  • All lab reports and imaging studies submitted
  • Prior authorization confirmation number
  • Your provider's direct contact for follow-up questions

Portal Communication:

  • Use UnitedHealthcare's member portal to track PA status
  • Message your provider through their patient portal for updates
  • Keep screenshots of all communications and status updates

What to Expect:

  • Initial decision typically within 15 business days
  • Approval letters will include coverage details and any restrictions
  • Denials must include specific reasons and appeal instructions

Respectful Persistence: Following Up Effectively

Appropriate Follow-Up Cadence:

  • Week 1-2: Allow processing time, check portal status
  • Week 3: Contact provider's office for status update
  • Week 4: If no decision, ask provider to call UnitedHealthcare
  • Beyond 15 business days: File complaint with Georgia DOI if needed

How to Escalate Politely:

  • Always work through your provider's office first
  • Document all communication dates and representatives spoken with
  • Request supervisor involvement if standard timeline is exceeded
  • Consider involving Counterforce Health for appeals assistance

Coverage Requirements at a Glance

Requirement What It Means Where to Find It
Prior Authorization Required before starting treatment UnitedHealthcare Provider Portal
Genetic Testing SMPD1 pathogenic variants Order through genetics lab
Enzyme Assay ASM activity <10% normal Specialized metabolic lab
Specialist Prescription Must be prescribed by appropriate specialist Metabolic/genetic specialist
Medical Necessity Letter Detailed clinical justification Provider creates with evidence
Baseline Assessments Organ function and size measurements Recent labs and imaging

Appeals Playbook for Georgia

Internal Appeal (First Level):

  • Timeline: File within 180 days of denial
  • Method: UnitedHealthcare member portal or written request
  • Decision: Within 30 days (expedited: 72 hours for urgent cases)

External Review (Final Level):

Required Documents for Appeals:

  • Original denial letter
  • Medical necessity letter
  • All supporting clinical documentation
  • Any additional evidence not previously submitted
Important: Georgia's external review process is binding on UnitedHealthcare. If approved, they must cover the treatment.

Consumer Support Resources:

Common Denial Reasons & Solutions

Denial Reason How to Overturn
"Not medically necessary" Strengthen functional impact documentation, add quality of life measures
"Experimental/investigational" Cite FDA approval and published clinical trial data
"Insufficient diagnostic evidence" Ensure both genetic testing and enzyme assay results are included
"Alternative treatments available" Document failure/intolerance of supportive care options
"Site of care restriction" Verify approved infusion centers, request exception if needed
"Quantity limits exceeded" Provide weight-based dosing calculations and monitoring plan

FAQ

How long does UnitedHealthcare prior authorization take in Georgia? Standard prior authorization decisions are made within 15 business days. Expedited reviews for urgent cases are completed within 72 hours.

What if Xenpozyme is non-formulary on my plan? Non-formulary medications can still be covered through the medical exception process with strong clinical justification and documentation of medical necessity.

Can I request an expedited appeal if my condition is worsening? Yes, if delaying treatment poses serious risk to your health, you can request expedited internal and external reviews in Georgia.

Does step therapy apply to Xenpozyme? UnitedHealthcare may require documentation that supportive care measures are insufficient, but true step therapy (trying similar drugs first) typically doesn't apply since no alternatives exist for ASMD.

What financial assistance is available while waiting for approval? The Assistance Fund offers an ASMD Financial Assistance Program covering copays, deductibles, and treatment costs for eligible patients.

How much does Xenpozyme cost without insurance? Wholesale acquisition cost ranges from $1,515 per 4mg vial to $7,576 per 20mg vial, with total monthly costs often exceeding $15,000 depending on patient weight and dosing.

Can I start treatment while my appeal is pending? This depends on your clinical situation. Discuss with your doctor whether delaying treatment poses risks, as this may qualify you for expedited review processes.

What happens if both internal and external appeals are denied? After exhausting administrative appeals, legal options may be available. Consult with healthcare attorneys specializing in insurance coverage disputes.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance company for guidance specific to your situation. Coverage policies and procedures may change; verify current requirements with UnitedHealthcare and Georgia insurance regulators.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.